Human CellExp™ Podoplanin

Biomolecule/Target: N/A

Synonyms: Podoplanin; Aggrus; Glycoprotein 36; Gp36; PA2.26 antigen; T1-alpha; T1A; PDPN; PSEC0003; PSEC0025

Alternates names: Podoplanin; Aggrus; Glycoprotein 36; Gp36; PA2.26 antigen; T1-alpha; T1A; PDPN; PSEC0003; PSEC0025

Taglines: A 36 kDa type I transmembrane sialoglycoprotein

Taglines: USA

Country of Animal Origin: N/A

NCBI Gene ID #.: 10630

NCBI Gene Symbol: N/A

Gene Source: Human

Accession #: Q86YL7-3

Recombinant: TRUE

Source: HEK293 cells

Purity by SDS-PAGE #: ≥ 95% by SDS-PAGE

Assay: N/A

Purity: N/A

Assay #2: N/A

Endotoxin Level: < 0.1 EU/μg of the protein as determined by LAL method.

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: The protein migrates as a band at 50-65kDa in SDS-PAGE.

Concentration: N/A

Appearance: Liquid

Physical form description: Lyophilized protein

Reconstitution Instructions: Reconstitute to a concentration of 0.1-0.5 mg/ml in sterile distilled water.

Background Information: Podoplanin is a 36 kDa type I transmembrane sialoglycoprotein. Podoplanin is widely expressed in different cells such as glomerular podocytes, type I alveolar cells, osteocytes, mesothelial cells, choroid plexus, glia cells, some neurons, fibroblasts, etc. It is also expressed in lymphatic endothelial cells and can be used to detect lymphangioma, Kaposi’s sarcoma, epithelioid mesothelioma, hemangioblastoma, seminoma and angiosarcoma which may have undergone lymphatic differentiation.

Amino acid sequence: Glu97–Lys199

Handling: Centrifuge the vial prior to opening.

Usage: For Research Use Only! Not to be used in humans